-
221
-
222
Combination Immunotherapy with 4-1BBL and CTLA-4 Blockade for the Treatment of Prostate Cancer
Published 2012-01-01“…These results suggest that combining activation of 4-1BB and blockade of CTLA-4 may offer a new strategy for prostate cancer immunotherapy.…”
Get full text
Article -
223
The Role of Immunotherapy in Extensive Stage Small-Cell Lung Cancer: A Review of the Literature
Published 2019-01-01“…Nevertheless, prognostic biomarkers to immunotherapy response remain to be discovered.…”
Get full text
Article -
224
Immunotherapy versus targeted therapy in management of recurrent squamous cell carcinoma of oral tongue
Published 2024-06-01“…Background: Targeted therapies, and more recently immunotherapy, have dramatically changed the landscape of treatments in oral cavity cancers and improved clinical outcomes. …”
Get full text
Article -
225
Comment on “Exploring PD-1 methylation in oral cancer: A crucial frontier in immunotherapy”
Published 2024-09-01Get full text
Article -
226
Immunotherapy-Induced Overlap Syndrome: Myositis, Myasthenia Gravis, and Myocarditis—A Case Series
Published 2024-01-01Get full text
Article -
227
-
228
Unveiling the role of SYNGR4 in breast cancer development: a novel target for immunotherapy
Published 2025-01-01“…SYNGR4 overexpression affects breast cancer proliferation, migration, and tumor immune infiltration, and promotes breast cancer tumor-associated macrophage polarization toward M2.DiscussionSYNGR4 overexpression can affect the prognosis of breast cancer patients by promoting M2 polarization of tumor-associated macrophages in breast cancer, and this molecule may be a novel target for breast cancer immunotherapy.…”
Get full text
Article -
229
Cytokine-armed oncolytic herpes simplex viruses: a game-changer in cancer immunotherapy?
Published 2024-05-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
230
A Review on the Application of PD-1 Blockade in EBV-Associated Nasopharyngeal Carcinoma Immunotherapy
Published 2022-01-01“…Although radiotherapy and chemotherapy are effective treatments for NPC, they have immunosuppressive effects. Immunotherapy has got considerable attention of clinicians for cancer treatment in recent years due to proven success of PD-1/PD-L 1 inhibition in solid tumors trials. …”
Get full text
Article -
231
Autologous CIK Cell Immunotherapy in Patients with Renal Cell Carcinoma after Radical Nephrectomy
Published 2013-01-01Get full text
Article -
232
Single component organic photosensitizer for tumor Photodynamic/Photothermal immunotherapy via apoptosis and pyroptosis
Published 2025-03-01Subjects: Get full text
Article -
233
-
234
Fluorescence Lifetime Imaging of NAD(P)H in Patients’ Lymphocytes: Evaluation of Efficacy of Immunotherapy
Published 2025-01-01Subjects: “…immunotherapy…”
Get full text
Article -
235
Long-Term Survival and PSA Control with Radiation and Immunotherapy for Node Positive Prostate Cancer
Published 2009-01-01“…We describe a patient with node positive prostate cancer treated with radiation, androgen deprivation, and immunotherapy with long-term overall survival and PSA control. …”
Get full text
Article -
236
Neoadjuvant anti-PD-1-based immunotherapy: evolving a new standard of care
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
237
Unfavorable Tumor Responses to Immunotherapy in the Liver: Lessons Learned from Clinical and Preclinical Studies
Published 2023-04-01“…Objective: Immunotherapy with immune checkpoint inhibitors (ICIs) has become a standard of care for many malignancies. …”
Get full text
Article -
238
Antibodies against the multifaceted cathepsin D protein open new avenues for TNBC immunotherapy
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
239
Mitochondria-targeted photothermal-chemodynamic therapy enhances checkpoint blockade immunotherapy on colon cancer
Published 2025-04-01Subjects: “…Checkpoint blockade immunotherapy…”
Get full text
Article -
240
Gene Carriers and Transfection Systems Used in the Recombination of Dendritic Cells for Effective Cancer Immunotherapy
Published 2010-01-01“…Therefore, it is essential to improve the transfection efficiency of DC-based vaccination in immunotherapy. In several studies, DCs were genetically engineered by tumor-associated antigens or by immune molecules such as costimulatory molecules, cytokines, and chemokines. …”
Get full text
Article